Japanese Pharmaceuticals & Biotech High Growth Potential Companies

GNI Group

Market Cap: JP¥136.0b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Noile-Immune Biotech

Market Cap: JP¥6.5b

Researches and develops CAR-T cells for cancer immunotherapies.

Japan Tissue Engineering

Market Cap: JP¥19.3b

Engages in the regenerative medicine business in Japan.

Sawai Group Holdings

Market Cap: JP¥216.5b

Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.

Kidswell Bio

Market Cap: JP¥11.1b

Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.

Takara Bio

Market Cap: JP¥97.7b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

Daiichi Sankyo Company

Market Cap: JP¥6.4t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥13.7t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

PeptiDream

Market Cap: JP¥216.6b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Nxera Pharma

Market Cap: JP¥76.0b

Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.

Takeda Pharmaceutical

Market Cap: JP¥6.9t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥67.4b

A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.

JCR Pharmaceuticals

Market Cap: JP¥76.5b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Daito PharmaceuticalLtd

Market Cap: JP¥37.3b

Engages in the manufacture and sale of pharmaceutical products worldwide.

Zeria Pharmaceutical

Market Cap: JP¥86.9b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.